These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 12211782

  • 1. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB, Harper AM.
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [Abstract] [Full Text] [Related]

  • 2. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee.
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [Abstract] [Full Text] [Related]

  • 3. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Jan; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 4. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients.
    Brown RS, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, Lobritto S, Emond JC.
    Liver Transpl; 2002 Mar; 8(3):278-84. PubMed ID: 11910574
    [Abstract] [Full Text] [Related]

  • 6. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL, Kulkarni S, Harper A, Millis JM, Cronin DC.
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [Abstract] [Full Text] [Related]

  • 7. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J, Downey KK, Akoad M, Cacciarelli TV.
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [Abstract] [Full Text] [Related]

  • 8. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
    Freeman RB, Rohrer RJ, Katz E, Lewis WD, Jenkins R, Cosimi AB, Delmonico F, Friedman A, Lorber M, O'Connor K, Bradley J.
    Liver Transpl; 2001 Mar; 7(3):173-8. PubMed ID: 11244156
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for liver transplantation waiting list mortality.
    Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
    [Abstract] [Full Text] [Related]

  • 10. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH, Son JH, Kim TW.
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [Abstract] [Full Text] [Related]

  • 11. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Sep; 40(6):1903-5. PubMed ID: 18675084
    [Abstract] [Full Text] [Related]

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 13. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [Abstract] [Full Text] [Related]

  • 14. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [Abstract] [Full Text] [Related]

  • 15. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.
    Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH.
    Hepatology; 2004 Mar; 39(3):764-9. PubMed ID: 14999695
    [Abstract] [Full Text] [Related]

  • 16. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP, Bartels M, Hauss J, Fangmann J.
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [Abstract] [Full Text] [Related]

  • 17. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS, Deisanti D, Seva-Pereira T, Almeida JR, Yamanaka A, Boin IF, Soares EC.
    Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
    [Abstract] [Full Text] [Related]

  • 18. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 19. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 20. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G, Andorno E, Morelli N, Antonucci A, Bottino G, Mondello R, Castiglione AG, Valente R, Ravazzoni F, Di Domenico S, Valente U.
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.